Announcements Trials
Browse Landscape

Phase

Phase 2 31Phase 4 7Phase 3 6Phase 1 3Phase NA 2

Status

Unknown 6Completed 4Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 5Tumor-Agnostic 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Non-squamous Non-small Cell Lung Cancer 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

Cisplatin 129Radiotherapy 94Carboplatin 82Fluorouracil 77Paclitaxel 76Cyclophosphamide 76Gemcitabine 71Capecitabine 66Docetaxel 64Doxorubicin 59Oxaliplatin 57Etoposide 57Leucovorin 48Vincristine 46Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Pemetrexed 27Neoadjuvant Therapy 26Irinotecan 25Tamoxifen 24Prednisone 23Methotrexate 21Rituximab 19Vinorelbine 18Radiotherapy, Intensity-Modulated 18Peripheral Blood Stem Cell Transplantation 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Unknown × icotinib × Clear all
NCT02448797 2021-07-20

EVIDENCE

Betta Pharmaceuticals Co., Ltd.

Phase 3 Unknown
320 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04797806 2021-03-15

SAINT

Tianjin Medical University Cancer Institute and Hospital

Phase 3 Unknown
206 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04058704 2019-08-15

SMART

Betta Pharmaceuticals Co., Ltd.

Phase 3 Unknown
296 enrolled
CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03992885 2019-06-20

Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.

Tianjin Medical University Cancer Institute and Hospital

Phase 3 Unknown
70 enrolled
Thoracic

Non-squamous Non-small Cell Lung Cancer

NCT02125240 2018-07-16

ICWIP

Betta Pharmaceuticals Co., Ltd.

Phase 3 Unknown
124 enrolled
Tumor-Agnostic

Adenocarcinoma

NCT02883543 2016-08-30

First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phase 3 Unknown
330 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡